Eli Lilly and Company (LLY) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Drug Manufacturers - General industria. La empresa tiene su sede en Indianapolis, IN, United States. El CEO actual es David A. Ricks.
LLY tiene fecha de IPO 1972-06-01, 47,000 empleados a tiempo completo, cotiza en el NYSE, una capitalización de mercado de $871.6B.
Eli Lilly and Company is a global pharmaceutical company that discovers, develops, and markets a comprehensive portfolio of human pharmaceuticals across multiple therapeutic areas. The company's offerings span diabetes management with products like Humalog and Humulin insulins, oncology with agents including Alimta, Cyramza, and Verzenio for various cancers, immunology with Olumiant and Taltz for rheumatoid arthritis and psoriatic conditions, and neuroscience with medications such as Cymbalta and Zyprexa. Additionally, Eli Lilly provides treatments for other indications including erectile dysfunction, osteoporosis, and COVID-19, supported by strategic collaborations with leading biotechnology firms. Founded in 1876 and headquartered in Indianapolis, Indiana, the company maintains a strong commitment to innovation and therapeutic advancement across its diverse drug pipeline.
